TrialX Updates: Leadership Insights, Patients as Partners 2026, Global Patient Recruitment and More…
As we return from an energizing week at SCOPE 2026 in Orlando, one thing is clear: the industry conversation has evolved. The focus has shifted from experimentation to execution — from “Should we modernize?” to “How do we operationalize smarter enrollment now?” For us at TrialX, SCOPE was not just about booth traffic, but about reinforcing a critical reality: clinical trial success in 2026 depends on reliable, integrated patient engagement and enrollment infrastructure — not disconnected tools.
The enrollment landscape is increasingly complex. Sites are stretched, sponsors face accelerating timelines, and regulators continue to prioritize transparency and participant-centricity. Across discussions, a strong consensus emerged: enrollment can no longer be treated as a standalone campaign, but as a core, measurable part of the broader clinical research ecosystem.
Key Themes from Our Conversations
Operationally Reliable Trial Finders: Many organizations are still relying on static directories or internally built tools. What we discussed repeatedly is the challenge of maintaining accuracy, searchability, compliance, and real-time performance at scale. TrialX’s platform powers dynamic trial discovery and referral workflows that connect interest to actual enrollment outcomes — not just clicks.
Enrollment as Infrastructure, Not a Tactic: Recruitment is often treated as a short-term service layered onto a study. Increasingly, leaders are recognizing the need for persistent registries, reusable prescreeners, analytics dashboards, and site-connected workflows that compound value over time.
Analytics That Matter: A recurring question at SCOPE: “Can you show us what’s actually converting?” Visibility into referral flow, site follow-up, patient drop-off points, and campaign performance is no longer optional. Data transparency is becoming foundational to how sponsors and CROs evaluate partners.
Participant-Centered Design: As decentralized and hybrid trials continue to evolve, reducing friction for participants is critical. From intuitive prescreeners to compliant communication pathways, engagement must feel simple on the front end — even if the infrastructure behind it is sophisticated.
As regulatory expectations evolve and global competition for participants intensifies, it’s clear that enrollment performance is closely tied to the strength of technology and operational processes. To everyone we connected with in Orlando, thank you for the meaningful conversations. For those who couldn’t attend, we’d be glad to share how TrialX supports sponsors, CROs, advocacy groups, and sites with scalable enrollment solutions that drive measurable outcomes. The future of clinical research will be built on connected, intelligent platforms that reliably turn patient interest into participation. Looking forward to continuing the conversation in Boston at Booth #15 at the Patients as Partners in Clinical Research 2026.
What’s New at TrialX! 🚀
❇️ UPCOMING CONFERENCE
We’re excited to be at the 13th Annual Patients as Partners in Clinical Research conference as associate sponsors and look forward to seeing you in Boston at our Booth #15. Don’t miss the panel at 3:50 PM EST on March 24, where our Senior Director of Client Services, Wes Martz, will speak alongside Krista Goedel from Sanofi on innovative approaches to improve global patient recruitment and access to clinical trials. Also, take a moment to recharge at the 12:10 PM yoga break with our Co-founder and CEO, Sharib Khan. If you’re attending, be sure to stop by and connect with our team!
❇️ PRODUCT HIGHLIGHTS
We supported a Top-5 pharma in successfully reaching their enrollment goal for a celiac disease clinical trial. By enabling engagement in 14 languages across 18 countries, and soon expanding to 40, we are proud to help sponsors and study teams run more inclusive trials and connect with the right participants in the right language, from local to global studies. Learn how we’re breaking down barriers to boost trial participation.
In recognition of Rare Disease Day, we’re proud of our partnership with TSC Alliance, an internationally recognized nonprofit dedicated to improving the lives of those affected by tuberous sclerosis complex (TSC), a rare genetic condition that causes tumors in multiple organs. As a rare disease, TSC often faces limited funding, fewer research opportunities, and slower therapeutic development. Through our AI-based clinical trial finder, we are humbled to help individuals and families discover relevant studies faster and stay informed through a volunteer registry. With tailored questions, smart filters, and clear trial summaries, the platform provides a personalized, user-friendly experience that makes clinical research more accessible to the rare disease community. Learn more.
Space missions demand health monitoring in extreme, low-connectivity environments—something missions like Artemis II clearly underscore. TrialX Space Health Systems is an offline-capable, AI-powered platform designed to collect and analyze diverse health datasets—from wearables to genomics—even without connectivity—enabling remote health research wherever the mission goes. In collaboration with the Translational Research Institute for Space Health (TRISH), we’ll be sharing more at the International Workshop on Space (IWS) in April and at the Aerospace Medical Association (AsMA) Annual Meeting in May. Learn more.
📺 MEDIA & PRESS
Our Co-founder & CEO, Sharib Khan, was recently interviewed by Clinical Research News and featured in their online article – Space Health Research Could Rack Up Many Earthly Dividends. The article sheds light on how our space health research innovations, in collaboration with Translational Research Institute for Space Health (TRISH), are helping collect vital human-health data from commercial spaceflights, not just for astronauts, but with far-reaching implications for clinical research on Earth. Read the full story.
🛰️ RECENT WEBINAR
As commercial spaceflight expands, Earth-dependent imaging continues to face real constraints, including microgravity-driven physiological changes, communication delays and limited bandwidth. In a recent TrialX webinar, we explored how imaging systems can operate autonomously in zero-connectivity, high-risk environments and what these advances mean for remote and decentralized care on Earth. The discussion is relevant for teams working across space health, diagnostics, telemedicine, and clinical research.
RECENT CURETALKS 
🧬 FEATURED CLINICAL STUDIES
Powered by TrialX
Health Beyond Medicine: Researchers at the Indiana University are studying how well surveys capture everyday social needs such as housing, food, and transportation. Participants complete an online survey, and researchers may review medical records to better understand how these non-medical factors influence health and care for older adults.
Smoking and Vaping Patterns Study: Penn Medicine researchers are examining how younger and older adults who both smoke cigarettes and use e-cigarettes make decisions about their tobacco use. Participants attend in-person sessions and track their smoking and vaping behaviors over time to help researchers better understand usage patterns.
High-Risk Asthma Treatment Trial: Researchers are testing an investigational medication to see if it can improve outcomes for adults with high-risk asthma who are not eligible for biologic therapies. Participants receive either the study drug or a placebo over 64 weeks, helping researchers evaluate its safety and effectiveness on asthma control.
Eat Well Heart Failure: In recognition of American Heart Month, we’re spotlighting a trial evaluating a “Food is Medicine” produce prescription program for adults with heart failure. The study examines whether providing healthy foods—along with varying levels of behavioral support—can improve health outcomes and reduce hospital visits for people living with congestive heart failure.
🌎 AROUND THE WEB
👁️ GLP-1 eye opener: Popular weight-loss drugs may help preserve vision as we age.
💊 Parkinson’s pill: Researchers test a new oral treatment for early-stage Parkinson’s.
🚀 Orbit control: SpaceX rolls out a space traffic system to manage orbit congestion.
🤖 AI 2026 outlook: Experts share bold predictions for AI in healthcare.
🌌 Deep-space: Artemis II will stress-test human health in deep space like never before.
‼️ NOTEWORTHY
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to simplify patient recruitment management and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!
All the best,
Team TrialX
